Correction to: Infect Dis Ther (2023) 12:1695–1713 https://doi.org/10.1007/s40121-023-00826-w


The treatment strategies described in Fig. 1 for the patient groups “vancomycin susceptible; ABPC susceptible” and “vancomycin susceptible; ABPC resistant” were labelled incorrectly. This error only appeared in Fig. 1, all analyses and conclusions reported in the paper were not affected by this error. The revised Fig. 1 is given below. The original article has been corrected.

Fig. 1
figure 1

Model schematic: Patients with Enterococcus faecium infections are treated according to the treatment regimen based on their indication and susceptibility. The deterministic treatment pathway estimates outcomes for cost, utility and survival based on the probabilities of successful or unsuccessful treatment associated with each treatment and indication. ABPC = ampicillin, BSI = bloodstream infection, DAP = daptomycin, IAI = intra-abdominal infection, LZD = linezolid, UTI = urinary tract infection. *Alternative treatment strategy used to treat patients with bloodstream infections